Beijing Approves First CAR-T Cell Therapy Drug for Market Launch
Beijing ImmunoTherapy Pharmaceuticals Co., Ltd. announced its first independently developed CAR-T cell therapy, Bokinolensel Injection, received a Drug Registration Certificate from China's National M
VolFlash analysisQueued
This event is in the analysis queue — usually done within 40s. Refresh to see it.
One email a day — don't miss the big ones
The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Related events
Published：2026-11-05 18:18:21 · Source：wallstcn · Automatically aggregated and analysed — verify against the original source.